主題演講

Stephen Fesik

Targeting Ras and MYC for the Treatment of Cancer

Stephen Fesik, Ph.D.

Professor of Biochemistry, Pharmacology, and Chemistry, Orrin H. Ingram II Chair in Cancer Research, Vanderbilt University School of Medicine

Craig Crews

以活性為基礎的蛋白質體學:全球規模的蛋白質與配體之發現

Benjamin F. Cravatt, Ph.D.

Professor and Co-Chair, Department of Molecular Medicine, The Scripps Research Institute


Cambridge Healthtech Institute主辦的13th Annual Drug Discovery Chemistry(第13屆藥物開發化學年會)是以藥廠及生技企業等醫藥化學領域研究開發專家為對象的熱鬧年會。 本年會焦點圍繞在小分子候補藥物的開發與改良相關課題,不但準備了許多有趣的會議內容,與會人士也可依其感興趣的主題自由安排豐富的客製化議程。 2018年的會議拓展了「Small Molecules for Cancer Immunotherapy(癌症免疫療法的小分子藥物)」範疇,新增「Ubiquitin Proteasome System Inhibitors(泛素-蛋白酶體系統抑制劑)」、「Targeting Complex Membrane Proteins(複雜的膜蛋白質標的化)」、「Lead Optimization for Drug Safety(以提升藥物安全性為目的之先導化合物最佳化)」等主題。

Event Features

  • More than 150 presentations
  • 750+ high-level participants
  • 70+ posters
  • Interactive roundtable, breakout & panel discussions
  • "Track-hop" between concurrent meetings
  • Exclusive exhibit & poster viewing hours
  • Dedicated networking opportunities

Short Courses

Maximize your educational and networking opportunities while in San Diego by adding on one or more interactive short courses!